Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Medivation Inc.

Medivation Inc. (MDVN)

Market is closed
News
Medivation Inc (MDVN), Amarin Corporation plc (ADR) (AMRN), Abbott Laboratories (ABT): Adage Capital Management Owns 5.4% of This Company

Medivation Inc (MDVN), Amarin Corporation plc (ADR) (AMRN), Abbott Laboratories (ABT): Adage Capital Management Owns 5.4% of This Company

According to a 13G filed with the SEC, Adage Capital Management, a large hedge fund managed by Phil Gross and Robert Atchinson, owns just over 4 million shares of Medivation Inc (NASDAQ:MDVN), a $3.6 ...

Keep Reading →

April 4th, 2013 - Hedge Funds

Johnson & Johnson (JNJ), Dendreon Corporation (DNDN): A Magical Drug that Could Change Lives

The biotech sector is perhaps the most volatile and risk-prone sector in the market, but investors still love it.

Keep Reading →

March 26th, 2013 - News

What's Inside Johnson & Johnson (JNJ)'s Pharmaceuticals Business? - Medivation Inc (MDVN), Merck & Co., Inc. (MRK)

What's Inside Johnson & Johnson (JNJ)'s Pharmaceuticals Business? - Medivation Inc (MDVN), Merck & Co., Inc. (MRK)

What doesn't Johnson & Johnson (NYSE:JNJ) produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.

Keep Reading →

March 13th, 2013 - News

Will Johnson & Johnson (JNJ) Help You Retire Rich?

Will Johnson & Johnson (JNJ) Help You Retire Rich?

Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.

Keep Reading →

March 11th, 2013 - News

Johnson & Johnson (JNJ), Dendreon Corporation (DNDN) - Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players

Johnson & Johnson (JNJ), Dendreon Corporation (DNDN) - Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players

As I commented last week, cancer statistics are both staggering and disappointing.

Keep Reading →

March 5th, 2013 - News

5 Can't-Miss Health-Care Events This Week: Zogenix, Inc. (ZGNX), Ariad Pharmaceuticals, Inc. (ARIA)

5 Can't-Miss Health-Care Events This Week: Zogenix, Inc. (ZGNX), Ariad Pharmaceuticals, Inc. (ARIA)

Normally we have a nice blend of health-care events to take notice of each week.

Keep Reading →

February 24th, 2013 - News

Dendreon Corporation (DNDN) Earnings: An Early Look

Dendreon Corporation (DNDN) Earnings: An Early Look

Earnings season is now starting to wind down, with most companies already having reported their quarterly results.

Keep Reading →

February 22nd, 2013 - News

Can Johnson & Johnson (JNJ)'s Zytiga Build on a Historic 2012?

Can Johnson & Johnson (JNJ)'s Zytiga Build on a Historic 2012?

Johnson & Johnson (NYSE:JNJ) may offer well-known personal-care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio of market-leading therapeutic compounds.

Keep Reading →

February 20th, 2013 - News

Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)